- All 55 AGs from the states and territories have settled with Purdue Pharma, Inc., and its owners, members of the Sackler family, to resolve allegations related to the company’s role in fueling the opioid crisis.
- According to the New York AG’s complaint, Purdue—along with other opioid manufacturers and distributors—contributed to the opioid epidemic by engaging in false and deceptive marketing about the addictiveness of opioids and by failing to prevent the unlawful diversion of controlled substances, violating numerous state laws.
- The Sacklers will pay $1.5 billion and Purdue will pay roughly $900 million in the first payment, which is expected in early 2026 pending settlement approval, and subsequent payments will be $500 million after one year, an additional $500 million after two years, and $400 million after three years.
- We have previously covered 16 AGs’ settlement in principle with Purdue and the Sacklers.